IPM Magazine
, Volume 06
Website Content from This Issue
Molecular Dx
Treading with Caution: PGx Test Developers Pursue Dialogue as FDA Maintains Enforcement Stance
November 7, 2019
Molecular Dx
2020 Vision: Industry Leaders Share Predictions of What May Shape Precision Medicine in the Coming Year
November 6, 2019
Molecular Dx
Search and Detect (for Free): Invitae Pursues Sponsors for Free Genetic Testing Programs Targeting Four Conditions
October 8, 2019
News & Features
Ending the Odyssey: Leveraging Improved Sequencing Technology, Rare Disease Diagnosis Speeds Up and Spreads Out
October 7, 2019
News & Features
Proper Prescribing: Pharmacogenetics Testing Gains Traction but Requires a Delicate Balancing Act
October 7, 2019
News & Features
Whose Genes Anyway?: Congressional action on Section 101 of U.S. patent law could reopen path to patenting genes
July 18, 2019
Molecular Dx
CRISPR Detectives: Startups seek to expand access to diagnostics with inexpensive CRISPR-based tests
July 17, 2019
News & Features
The Breadth of Precision Medicine at ASCO 2019: From early detection to progress in difficult-to-treat cancers and previously undruggable targets
July 16, 2019
Molecular Dx
Mining the Microbiome: Microbiome startups are proliferating, exploring new markets, and colonizing diverse therapeutic niches
July 16, 2019
Molecular Dx
Not if. When: Metabolomics’ Impact in Cancer Treatments May be Just Around the Corner
May 30, 2019
Molecular Dx
Betting on Blood: Liquid Biopsy Companies Pursuing both Early- and Late-Stage Cancer Detection
May 24, 2019
Molecular Dx
Patient Investment: PerkinElmer, Helix Partner to Launch ACMG 59 Genetic Screening Test
May 24, 2019
News & Features
We Have the Tools to Advance Precision Medicine, Why Aren’t We Using Them?
April 2, 2019
